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Abstract
Purpose of Review This article reviews the latest develop-
ments in tissue engineering for the larynx with a specific focus
on the treatment of laryngeal cancer.
Recent Findings Challenges in tissue engineering a total lar-
ynx can be divided into scaffold design, methods of re-
mucosalization, and how to restore laryngeal function. The
literature described a range of methods to deliver a laryngeal
scaffold including examples of synthetic, biomimetic, and bi-
ological scaffolds. Methods to regenerate laryngeal mucosa
can be divided into examples that use a biological dressing
and those that engineer a new mucosal layer de novo. Studies
aiming to restore laryngeal function have been reported, but to
date, the optimum method for achieving this as part of a total
laryngeal transplant is yet to be determined.
Summary There is great potential for tissue engineering to
improve the treatments available for laryngeal cancer within
the next 10 years. A number of challenges exist however and
advances in restoring function must keep pace with develop-
ments in scaffold design.
Keywords Tissue engineering . Larynx . Regenerative
medicine . Laryngeal cancer . Larynx transplant
Introduction
Laryngeal cancer is the second most common airway cancer
after lung cancer with an estimated global incidence of
157,000 per annum [1]. Within the USA, an estimated
13,430 new cases have been diagnosed in 2016 with an esti-
mated annual mortality of 3620 [2]. Conventional treatments
for advanced laryngeal cancer can be divided into surgical and
organ preserving treatments. Surgical therapies involve either
a total or partial laryngectomies. Total laryngectomy involves
the complete resection of the larynx with the creation of a
tracheostome to create a new airway and a neo-pharynx to
preserve swallowing. Whilst this offers the chance for wide
surgical margins and good swallow function [3, 4], voice re-
habilitation is variable and there are additional psychological
and social impacts of having a permanent tracheostome that
impact on the quality of life [5, 6]. Partial laryngectomy en-
compasses procedures involving a sub-total resection of the
larynx to preserve function whilst aiming to achieve similar
rates of cure as total laryngectomy [7]. Function and quality of
life assessments have been demonstrated to be higher with this
approach compared to total laryngectomy although the subset
of patients in which this resection is possible is small and
problems with aspiration remain [8–10]. Organ preserving
therapies involve chemo-radiation with curative intent whilst
leaving the anatomical structures of the larynx to preserve
function. Survival rates have been shown to be comparable
to surgical treatments although swallow dysfunction and other
complications such as dryness andmucositis mean the optimal
form of treatment remains a source of on-going debate
[11–13]. The limitations of these treatment modalities have
led some to explore whether tissue engineering could provide
new therapeutic options.
Tissue engineering applies the principles of biological and
material science with engineering to restore or replace
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damaged tissue or organs. The ability to transplant a function-
ing tissue-engineered larynx would revolutionize the treat-
ment of laryngeal cancer by providing comparable rates of
cure to conventional treatments whilst preserving function.
Total cadaveric laryngeal transplantation has been reported
twice in the literature and demonstrates the feasibility of total
laryngeal replacement [14, 15]. A 14-year follow-up of the
first transplant describes how after a 10-year period, a slow
progressive chronic rejection process led to the organ becom-
ing nonfunctional and the larynx being explanted [16]. It is
possible that a tissue-engineered larynx would avoid this as it
would be repopulated with the patient’s own cells. To date,
reports on the delivery of a complete and functioning tissue-
engineered larynx are however absent from the literature. The
challenges involved in realizing this ambition are multiple and
can be divided into challenges in scaffold design, re-epitheli-
alization, and restoring laryngeal function.
Scaffold Design of a Tissue-Engineered Larynx
A tissue-engineered total laryngeal replacement would require
a scaffold that integrates with the host tissue, provides ade-
quate structural support, and allows for mobility to enable
laryngeal function. The first obvious target would be to engi-
neer the larynx from the regenerated cartilage. Cartilage has
the advantage of being biocompatible and exhibits a high ten-
sile strength whilst retaining elasticity. The ability to engineer
the cartilage in vitro has been extensively reported using a
variety of protocols [17–20]. In brief, the cartilage is harvested
from an autologous source such as the septum or auricle; the
chondrocytes separated and expanded in vitro before
reseeding onto a scaffoldmade from either biological, synthet-
ic or biomimetic material. The successful integration in vivo
of the engineered cartilage has remained problematic, howev-
er, with reports documenting strong inflammatory responses
and rapid degradation as well as difficulties in restoring an
adequate blood supply following transplantation [17, 21]. To
overcome this, the principle of in vivo tissue engineering has
been applied whereby the cartilage regenerates within a
vascularized structure in vivo to enable transplantation with
a preserved blood supply. An example of this can be seen in
work by Kamil et al. where chondrocytes sourced from auric-
ular cartilage were suspended in a biodegradable polymer and
implanted in the dorsum of a pig [22]. After 2 months, a
complete cartilage graft was harvested and used as part of a
laryngotracheal reconstruction with bronchoscopy and histol-
ogy demonstrating complete integration of the graft into the
host tissue.
The use of synthetic or biomimetic scaffolds has the advan-
tage over cartilage scaffolds in that they can be more easily
fabricated to a specific size and shape and within a shorter
period of time. Several studies have reported on the use of a
polyprolene mesh coated with a spongy porcine collagen
manufactured using a dental cast of a hemilarynx [23, 24].
Following hemilaryngectomy in a canine model, the construct
is transplanted with a pre-clotted mixture of peripheral blood
and bone marrow-derived stromal cells or a fascia lata wrap.
After the first week, evidence of neo-mucosalization is dem-
onstrated and the constructs had integrated within the host
tissue.
Titanium has been used to reconstruct laryngotracheal re-
sections for airway stenosis in a number of cases with the
additional use of silk fibroin to facilitate better mucosal
healing [25–28]. Titanium is an attractive synthetic material
as it is hypoallergenic and comparatively cheap and has an
extensive safety profile in other applications such as laryngeal
fixation following fracture [29, 30]. Liu et al. used a titanium
mesh to reconstruct laryngeal defects in nine patients follow-
ing frontolateral vertical partial laryngectomy for T2 or T3
glottic cancer with the sternohyoid muscle being used to cover
the mucosal surface of the mesh and the outer surface covered
by omohyoid muscle [31]. No aspiration or laryngeal stenosis
was observed following implantation and fiberoptic inspec-
tion showed the mesh remained covered in the long term.
Biological scaffolds can be fabricated by decellularizing
donor tissue to remove the cellular content and thus immune
potential whilst retaining the extracellular matrix proteomic
cues that act as a map for regenerating cells [32]. Ansari
et al. used a 6 × 4 × 2 m section of decellularized porcine
larynx to replace a rectangular laryngeal defect in a pig model
[33]. The scaffold was pre-implanted within a neck muscle
flap for 4 weeks to re-vascularize before a sheet of engineered
buccal mucosa was grafted onto the surface and the construct
rotated on a muscle flap to repair the defect. Serial endoscopy
and computer tomography imaging showed the graft integrat-
ed within this host tissue and a layer of neo-mucosa regener-
ated within the first month. None of the six grafts implanted
led to any compromise in respiratory or swallowing function.
Aortic homografts are widely documented as a means of
reconstructing tracheal defects and are available as “off the
shelf” products that can be rapidly sourced and easily stored
[34–38]. They also retain the extracellular matrix needed for
successful regeneration and exhibit little immune response
from the recipient [38–40]. Zeitels et al. used cryopreserved
aortic homografts to reconstruct laryngeal defects in 15 pa-
tients undergoing partial laryngectomy for cancer [41]. The
strap or sternocleidomastoid muscles were affixed to the
extraluminal surface to promote revascularization, and a tra-
cheostomy was sited in all patients to protect the graft in the
initial post-operative phase. All of the 15 patients were suc-
cessfully decannulated by 10 weeks and exhibited laryngeal
phonation. Complete epithelialization took between 3 and
5 months and all but one of the patients resumed oral intake.
Whilst this study demonstrates the success in using biological
tissue to reconstruct partial defects, the subset of patients for
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which this type of resection is indicated is small and compar-
ative studies with conventional reconstructive methods fol-
lowing partial laryngectomy are yet to be performed.
Tissue Engineering to Restore Mucosal Function
Following scaffold selection, the means by which the mucosal
layer will be restored needs to be determined. An intact mu-
cosal layer is essential in any transplantation as it provides a
barrier against infection. In laryngeal transplantation, this is
even more relevant as the implant will be exposed to airborne
pathogens during respiration. Mucosa also has a number of
organ-specific specialized functions. Within the larynx, the
lamina propria layer of the vocal folds needs to be sufficiently
viscoelastic to allow for the transmission of the vibratory wave
during phonation. Conventional methods of tissue replace-
ment are not appropriate for restoring the mucosal layer in
an engineered laryngeal transplant. Split skin grafts are asso-
ciated with keratinization that leads to sloughing and infection
within the airway, and buccal mucosal grafts are restricted by a
limited supply of donor tissue. Myocutaneous flaps are ideal
for reconstructing large defects but are too bulky to reline the
complex three-dimensional surface of the larynx.
To achieve re-mucosalization of the laryngeal scaffold, sev-
eral options are available.
The first is to rely on the migration of the host’s native
epithelial cells to regenerate a new mucosal layer following
implantation, a process that can be potentiated by the use of
decellularized or biomimetic scaffolds that provide a favorable
matrix environment for regenerating epithelium [42]. The de-
lay in achieving re-mucosalization places that scaffold mate-
rial at risk of infection, although this risk can be negated by the
use of biological dressings, as seen with the use of a fascia lata
flap and clotted peripheral blood in works by Yamashita and
Kitani et al. [23, 24]. An alternative method might be to em-
bed the mucosal surface of the scaffold with pro-migratory
factors such as Rho-kinase inhibitor to potentiate the re-
epithelialization process [43, 44].
Another option to achieve re-mucosalization is to tissue
engineer a separate mucosal layer and graft it onto the scaffold
either before or during implantation. There are a number of
examples demonstrating how stratified squamous mucosa can
be engineered using autologous squamous cells expanded
from a small biopsy and seeded onto decellularized dermis
or collagen scaffolds (Fig. 1) [45, 46]. As with the engineered
cartilage, difficulties arise in grafting the in vitro engineered
mucosa onto a scaffold as, for the mucosa to survive, the
scaffold requires a blood supply to deliver nutrition to the
epithelial layer. Pre-vascularizing the scaffold within a muscle
flap is a potential solution and allowed for the successful
grafting of buccal mucosal grafts onto cadaveric trachea em-
bedded within radial forearm fascia in a series of partial
human tracheal transplants [47]. A similar method was
employed in the study by Ansari et al. where a segment of
decellularized porcine larynx was embedded within a neck
muscle flap and engineered squamous mucosa grafted onto
the surface 4 weeks later once a new blood supply had been
restored [33]. In this instance, the mucosa did not appear to
survive and acted as a biological dressing, protecting the scaf-
fold, whilst the host’s native epithelial cells covered the defect.
It could be argued that current examples of tissue-engineered
mucosa are not suitable for relining complex three-
dimensional scaffolds as the epithelial layer is exposed to
shear during the implantation phase and there is a delay in
re-vascularizing the epithelium following grafting leading to
cell death. A potential solution could be to implant epithelial
cells encased within collagen gel containing growth factors
and/or mesenchymal cells that provide support to the epithe-
lium whilst a blood supply is re-established. A similar tech-
nique has been used in gut engineering to reline a section of
decellularized small intestine [48].
Studies aiming to restore the viscoelastic properties of the
vocal fold lamina propria mainly involve the use of injectable
gels such as synthetic hyaluronic acid-dextran [49],
hyaluronic acid-based microgels [50], and collagen I compos-
ites [51]. These materials exhibit similar viscoelastic proper-
ties to healthy vocal fold lamina propria and are believed to be
pro-regenerative leading to a restoration of a viscoelastic layer
overtime [52]. The optimum material is still undecided how-
ever and whether a completely new lamina propria layer could
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Fig. 1 Tissue engineering buccal mucosa. a A biopsy of buccal mucosa
is taken and the epithelial cells and fibroblasts separated. These cells are
then expanded in culture and seeded onto a sheet of decellularized human
dermis. The construct is then matured at air-liquid interface to promote
differentiation. b A section of tissue-engineered buccal mucosa (BM) is
sutured onto a decellularized hemilarynx (DL) in vitro to restore the
mucosal layer in vitro
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as the majority of the studies examine the role of injectables in
vocal fold scarring [53, 54].
Tissue Engineering to Restore Dynamic Function
The larynx is a dynamic organ. During inspiration, the
vocal folds abduct to allow airflow and during phona-
tion, the folds adduct to generate vibration. During
swallowing, there are a complex series of movements
involving closure of the vocal and false cords, elevation
of the larynx, and reflection of the epiglottis to prevent
aspiration. A tissue-engineered total laryngeal transplant
would need to be able to provide all of these functions
if it is to overcome the shortcomings of conventional
treatments. A partial laryngeal transplant might not re-
quire full function providing the cricoarytenoid-nerve-
muscle unit is preserved in the un-resected larynx. The
tissue-engineered partial implant would aim to improve
upon the functional outcome of existing reconstructive
techniques following partial laryngectomy, namely prob-
lems with aspiration.
The cricoarytenoid-nerve-muscle unit needs to be re-
established in order to restore vocal fold movement. This
would require the laryngeal scaffold to have a functioning
cricoarytenoid joint, the successful regeneration and grafting
of the cricoarytenoid muscles, and regeneration of the mus-
cle’s nerve supply with appropriate central control. The suc-
cess of conventional joint replacement limits the role of tissue
engineering within this field to articular cartilage regeneration
to treat damage to existing joints [55, 56]. Advances in
nanoengineering might in the future deliver workable and bio-
compatible joint replacements small enough to restore
cricoarytenoid movement but so far, examples of the applica-
tion of this technology for this purpose are absent from the
literature.
The use of tissue engineering techniques to regenerate the
organized skeletal muscle has been well documented [57–59],
although studies regenerating the cricoarytenoid muscle spe-
cifically are lacking. Fishman et al. demonstrated that rabbit
cricoarytenoid dorsalis treated with latrunculin B, potassium
iodide, potassium chloride, and deoxyribonuclease achieves
total clearance of host DNAwith preservation of the scaffold
structural integrity and matrix components [60]. This provides
a decellularized cricoarytenoid muscle that can act as a scaf-
fold to regenerate a functioning cricoarytenoid muscle.
Reinnervation of the adductor and abductor cricoarytenoid
muscles is currently performed to prevent vocal cord muscle
atrophy and promote movement during respiration in cases of
vocal fold paralysis. The procedure is performed by means of
direct anastomosis of the adductor branch of recurrent laryn-
geal nerve with the ansa cervicalis and anastomosis of the
abductor branch to the phrenic nerve [61–63]. Reports on
functional outcome following reinnervation are promising
[63–65] and demonstrate the feasibility of this technique to
restore motor function in a tissue-engineered laryngeal trans-
plant. The engineered cricoarytenoid muscle would either
have to include neuromuscular endplates and a regenerated
laryngeal nerve to anastomose onto the existing laryngeal
nerve supply or the native laryngeal nerve would need to be
anastomosed directly onto the regenerated cricoarytenoid
muscle.
An alternative to reinnervation is the use of laryngeal
pacing. Pacing involves the insertion of electrodes into
the posterior cricoarytenoid muscle which deliver a
time-phased electric signal that is in sync with the re-
spiratory cycle to stimulate abduction of the vocal folds
during inspiration [66]. This technology has been trailed
in seven human patients with two of the seven subjects
exhibiting full reanimation for greater than 4 years [67].
Problems with biocompatibility and the lack of a sensor
to pace abduction with inspiration have meant this tech-
nology has not been widely adopted.
The restoration of swallowing function is more complex
because of the need for a coordinated series of laryngeal
movements. Transcutaneous neuromuscular electrical stimu-
lation of the pharyngeal muscles has been used to bring about
a coordinated muscle contraction in stroke patients suffering
with dysphagia with promising results [68], and this technique
could be adapted to reinnervate the larynx and coordinate the
swallowing mechanism. Soft robotics aims to deliver robotic
devices that are flexible and can potentially be used as im-
plants. This could deliver fully automated laryngeal move-
ment to restore swallow and voice although the technology
is still in the early development phases [69, 70]. A more rudi-
mentary example of a mechanical larynx has been trialed
using a titanium prosthesis with a concentric valve system that
opens to allow respiration and closes to avoid aspiration dur-
ing swallowing. Pre-clinical studies were encouraging in
terms of prosthetic integration [71, 72], although in the single
human case reported, the patient was still tracheostomy de-
pendent and due to the absence of a glottic sphincter phona-
tion was poor [73]. Long-term follow-up of this case and a
clinical trial involving this technology has not yet been
published.
Conclusions
There is great potential for tissue engineering to revolutionize
the treatment of laryngeal cancer in the form of a partial or
total laryngeal transplant within the next 10 years. A number
of challenges remain which are best addressed by a coordinat-
ed effort involving biological and material scientists, engi-
neers, surgeons, and allied health professionals. A decision
on the choice of scaffold and the optimal method of achieving
Curr Otorhinolaryngol Rep (2017) 5:42–48 45
integration with revascularization should form any early mile-
stone and should be developed in continuity with methods of
achieving complete re-mucosalization. Without function, total
laryngeal replacement would not be able to greatly improve
upon existing treatments for laryngeal cancer. Developments
in restoring laryngeal function must therefore keep pace with
developments in laryngeal scaffold and mucosal engineering.
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